Health physics
-
As a sequel to the article by Ken Lambert and Tara McKeon, we propose a model by which defects in lead aprons may easily be evaluated on a routine basis. The model is applicable to lead aprons of various lead equivalent thicknesses. ⋯ The model has been implemented as an annual quality check in a large medical facility. In this article we consider only dose-related rejection criteria, since financial aspects related to ALARA have already been addressed in the abovementioned article.
-
A sample of commercially available, charcoal adsorption type, short-term radon detectors was blind tested under controlled laboratory conditions in order to obtain a "snapshot" of the accuracy and precision of the detectors. The results of the controlled exposures were then compared to a previous field study of the same type of commercially available radon detectors. Radon detectors, purchased from seven different commercial vendors, were exposed to a reference (222)Rn gas concentration at the U. ⋯ Furthermore, the consistent over-reporting or under-reporting trends in the overall results for all three tests suggest a potentially widespread systematic bias for the individual companies that merits further investigation. It is unknown if this one-time "snapshot" represents the overall reliability of commercially available charcoal-based radon detectors. Nonetheless, the findings suggest the need for improved vigilance to assure that the public can rely on commercially available radon detectors to make an informed decision whether or not to perform additional testing or to mitigate.
-
The village of Dolon located about 60 km northeast from the border of the Semipalatinsk Nuclear Test Site in Kazakhstan is one of the most affected inhabited settlements as a result of nuclear tests by the former USSR. Radioactive contamination in Dolon was mainly caused by the first USSR nuclear test on 29 August 1949. As part of the efforts to reconstruct the radiation dose in Dolon, Cs and Pu in soil samples collected from 26 locations in the vicinity of and within the village were measured to determine the width and position of the center-axis of the radioactive plume that passed over the village from the 29 August 1949 nuclear test. ⋯ These results support the recently reported results. The data obtained here will provide useful information on the efforts to estimate radiation dose in Dolon as reliably as possible. Health Phys. 94(4):328-337; 2008.
-
The ETHOS Project, supported by the radiation protection research program of the European Commission (EC), was implemented in the mid-1990's with the support of the Belarus authorities as a pilot project to initiate a new approach for the rehabilitation of living conditions in the contaminated territories of the Republic. This initiative followed a series of studies performed in the context of the EC Community of Independent States cooperation program to evaluate the consequences of the Chernobyl accident (1991-1995), which clearly brought to the fore that a salient characteristic of the situation in these territories was the progressive and general loss of control of the population on its daily life. Furthermore, due to the economic difficulties during the years following the breakdown of the USSR, the population was developing private production and, in the absence of know-how and adequate means to control the radiological quality of foodstuffs, the level of internal exposure was rising significantly. ⋯ This paper discusses the post-Chernobyl context in the early- and mid-1990's, which led Belarus authorities to look for new approaches to protect the population residing in the long-term contaminated territories of the Republic. It then describes the ETHOS methodology and its main results. It also summarizes the general conclusions that can be drawn from the ETHOS Project.
-
The purpose of this retrospective study was to evaluate the whole-body clearance kinetics of I-3F8 monoclonal antibody, an anti-ganglioside 2 antibody, used in the treatment of pediatric patients with late-stage neuroblastoma (NB). Serial whole-body dose rate measurements were obtained on pediatric patients participating in phase I dose escalation studies of therapeutic I-3F8. Whole-body retention fractions were derived and fit for each treatment to exponential curves to determine both the effective half-lives and corresponding clearance fractions. 27 patients were administered I-3F8 over the course of cyclical administrations with a median administered activity of 2.5 GBq (range, 1-8.14 GBq), typically every 2-4 d for up to 9 treatment cycles. ⋯ The data from a subset of 12 treatments were fit to a bi-exponential curve with a rapid clearance component mean effective half-time of 16.9 h (range, 4.3-26 h) and a slower clearance component mean effective half-time of 65.5 h (range, 16.9-136 h). The use of whole-body dose rate measurements, obtained for patient-release and other radiation safety considerations, can be useful in estimating whole-body clearance kinetics for photon emitting radionuclide labeled mAbs and other therapeutic radiopharmaceuticals. In the case of I-3F8 for pediatric NB therapy, the demonstrated variability in effective half-time suggests the need for patient-specific tracer dosimetry for both optimization of treatment and radiation safety precaution decision-making.